A mathematical model of cellular swelling in Neuromyelitis optica

A mathematical model of cellular swelling in Neuromyelitis optica

Neuromyelitis Optica (NMO) is a severe neuro-inflammatory disease of the central nervous system characterized by predominant damage to the optic nerve and of the spinal cord. The pathogenic antibody found in the majority of patients targets the AQP4 channels on astrocytic endfeet and causes the cell...

Descripció completa

Dades bibliogràfiques
Autors principals:	Laranjeira, S, Symmonds, M, Palace, J, Payne, S, Orlowski, P
Format:	Journal article
Idioma:	English
Publicat:	Elsevier 2017

Ítems similars

The borderland of neuromyelitis optica.
per: Matthews, L, et al.
Publicat: (2009)

Use of mitoxantrone in neuromyelitis optica.
per: Kitley, J, et al.
Publicat: (2011)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
per: Waters, P, et al.
Publicat: (2015)

Magnetic resonance imaging in neuromyelitis optica.
per: Tackley, G, et al.
Publicat: (2014)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
per: Elsone, L, et al.
Publicat: (2012)

A practical guide to the treatment of neuromyelitis optica.
per: Palace, J, et al.
Publicat: (2012)

The evolving clinical spectrum of neuromyelitis optica
per: Viegas, S, et al.
Publicat: (2008)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
per: Matthews, L, et al.
Publicat: (2014)

Neuroimmunology: towards more-accurate diagnosis in neuromyelitis optica.
per: Fujihara, K, et al.
Publicat: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
per: Matthews, L, et al.
Publicat: (2013)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
per: Collongues, N, et al.
Publicat: (2013)

Neuromyelitis Optica
per: Goyal V, et al.
Publicat: (2009-10-01)

Neuromyelitis optica
per: Jacob Anu, et al.
Publicat: (2007-01-01)

Seasonal pattern of variation in neuromyelitis optica relapses
per: Elsone, L, et al.
Publicat: (2012)

NMO-IgG in the diagnosis of neuromyelitis optica.
per: Jarius, S, et al.
Publicat: (2007)

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
per: Viegas, S, et al.
Publicat: (2009)

Treatment of Neuromyelitis Optica: Review and Recommendations.
per: Kimbrough, D, et al.
Publicat: (2012)

Differential diagnosis of neuromyelitis optica spectrum disorders
per: Sung-Min Kim, et al.
Publicat: (2017-07-01)

Treatment of neuromyelitis optica: Review and recommendations
per: Kimbrough, D, et al.
Publicat: (2012)

NEUROMYELITIS OPTICA IN SOUTH WALES AND THE SOUTH WEST OF ENGLAND
per: Luppe, S, et al.
Publicat: (2012)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?
per: Downer, J, et al.
Publicat: (2012)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?
per: Downer, J, et al.
Publicat: (2012)

Influence of pregnancy on neuromyelitis optica spectrum disorder.
per: Kim, W, et al.
Publicat: (2012)

Pregnancy and neuromyelitis optica
per: Qiu-ying MA, et al.
Publicat: (2016-10-01)

An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica
per: Littleton, E, et al.
Publicat: (2006)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
per: Paul, F, et al.
Publicat: (2007)

Neuromyelitis optica relapses: race and rate, immunosuppression and impairment
per: Tackley, G, et al.
Publicat: (2016)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
per: Waters, P, et al.
Publicat: (2016)

Racial differences in neuromyelitis optica spectrum disorder
per: Kim, S, et al.
Publicat: (2018)

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
per: Kitley, J, et al.
Publicat: (2012)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
per: Nour, M, et al.
Publicat: (2014)

Paroxysmal dystonia and neuromyelitis optica
per: Felipe R. Schmidt, et al.
Publicat: (2012-04-01)

METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES
per: Kitley, J, et al.
Publicat: (2012)

Prognosis of Relapsing Neuromyelitis Optica
per: J Gordon Millichap
Publicat: (2003-03-01)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
per: Friedemann Paul, et al.
Publicat: (2007-04-01)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.
per: Kitley, J, et al.
Publicat: (2014)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
per: Kitley, J, et al.
Publicat: (2014)

Multisystem involvement in neuromyelitis optica
per: Megan M Langille, et al.
Publicat: (2015-01-01)

Good response to Ofatumumab in a child with severe relapsing Neuromyelitis Optica
per: Sedani, S, et al.
Publicat: (2012)

NEUROMYELITIS OPTICA SPECTRUM DISORDER AND CMV RETINITIS: A CASE REPORT
per: George, J, et al.
Publicat: (2012)